Eli Lilly
Eli Lilly develops medicines across multiple modalities including biologics and genetic medicine, with programs in diabetes, obesity, Alzheimer's disease, immune disorders, and oncology.
10-QNov 16Latest SEC filing
Nov 16Latest story
November 2026
October 2026
September 2026